Can a 30-Minute chat calm nerves before a port implant?
NCT ID NCT07559981
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a dedicated 30-minute consultation with a healthcare professional before getting an implantable port (a small device under the skin for chemotherapy) can lower patient anxiety. About 150 adults scheduled for the procedure will either get standard care or an extra consultation with photos and device demo. The goal is to see if this reduces anxiety and prevents issues like forgotten blood tests or medication errors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
paramedical consultation
What this could lead to
If it works, this could show that a simple pre-procedure chat with a healthcare professional reduces anxiety and prevents last-minute cancellations.
What could go wrong
This is a small, early-stage study (150 people) testing a non-drug intervention, so results may not apply broadly. The anxiety measure is subjective and may not capture real-world benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Grenoble
Grenoble, 38043, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••